CGTX vs V · $120.8M cap vs P/E 33, rev $40.00B
Cognition Therapeutics Inc (CGTX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
CGTX does not have a complete income-statement cache yet.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
CGTX currently screens at market cap $120.8M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the CGTX and V stock pages for the full models.
Not investment advice.